Stay updated with breaking news from Bradh Rovin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Authors offered practice points on lupus nephritis diagnosis, current treatments, response to therapy, and disease control. Experts summarized the current diagnosis, management, and follow-up of patients with lupus nephritis for informed care.
Obinutuzumab is being further evaluated in patients with active proliferative lupus nephritis. A post hoc analysis examined the effects of add-on obinutuzumab on several kidney function measures in patients with lupus nephritis.
Obinutuzumab is being further evaluated in patients with active proliferative lupus nephritis. A post hoc analysis examined the effects of add-on obinutuzumab on several kidney function measures in patients with lupus nephritis.
At week 76, complete renal response was achieved by 38 and 16% of patients receiving obinutuzumab and placebo, respectively
A post hoc analysis of the NOBILITY trial showed improved outcomes for patients taking obinutuzumab (Gazyva) compared with placebo.